{
      "ptx_code": "PTX060",
      "chem_name": "Atrazine",
      "casrn": "1912-24-9",
      "dtxsid": "DTXSID9020112",
      "smiles": "CCNC1=NC(NC(C)C)=NC(Cl)=N1",
      "inchikey": "MXWJVTOOROXGIU-UHFFFAOYSA-N",
      "label": "PTX060 | Atrazine",
      "drugbank_id": "",
      "use_class": "Pesticide",
      "tox_class": "Immunotoxicity; Genotoxicity; Neurotoxicity",
      "chem_name_user": "atrazine (ATZ)",
      "mw_g_mol": "215.69",
      "solubility_h2o_mol_liter": "1.99e-04",
      "source_solubility_h2o": "COMPTOX",
      "henry_coefficient_atm_m3_mol": "1.24e-08",
      "source_henry": "COMPTOX",
      "log_kaw_kh_rt": "6.30",
      "source_kaw": "LSER eq 1",
      "pka_acid": "",
      "pka_base": "1.70",
      "source_pka": "ACD pKa/GALAS",
      "log_kow_liter_liter": "2.61",
      "source_kow": "experimental  PhysPropNCCT",
      "log_dlipw_ph74_liter_liter": "2.14",
      "source_dlipw": "LSERD, cited in Escher 2017",
      "freely_dissolved_fraction": "0.82",
      "density_kg_liter": "1.24",
      "source_density": "COMPTOX",
      "average_mass": "215.69",
      "boiling_point": "",
      "source_boiling_point": "",
      "melting_point": "172.5 \u00b0C",
      "source_melting_point": "Jean-Claude Bradley Open Melting Point Dataset",
      "vapor_pressure": "2.89001E-7 mmHg",
      "source_vapor_pressure": "PhysPropNCCT",
      "baseline_drerio": "1260.00",
      "baseline_dmagna": "592.00",
      "baseline_celegans": "1288.25",
      "baseline_xlaevis": "379.40",
      "baseline_dmelanogaster": "5210.39",
      "baseline_cells": "5.55e-05",
      "baseline_cells_generic_micromole_liter_free_ec10": "4.56e-05",
      "moa_drugbank": "",
      "protein_binding": "",
      "moa_t3db": "",
      "aop": [
            {
                  "AOP_id": 6,
                  "AOP_name": "Antagonist binding to PPAR\u03b1 leading to body-weight loss "
            },
            {
                  "AOP_id": 18,
                  "AOP_name": "PPAR\u03b1 activation in utero leading to impaired fertility in males "
            },
            {
                  "AOP_id": 19,
                  "AOP_name": "Androgen receptor antagonism leading to adverse effects in the male foetus (mammals) "
            },
            {
                  "AOP_id": 34,
                  "AOP_name": "LXR activation leading to hepatic steatosis "
            },
            {
                  "AOP_id": 36,
                  "AOP_name": "Peroxisomal Fatty Acid Beta-Oxidation Inhibition Leading to Steatosis "
            },
            {
                  "AOP_id": 57,
                  "AOP_name": "AhR activation leading to hepatic steatosis "
            },
            {
                  "AOP_id": 58,
                  "AOP_name": "NR1I3 (CAR) suppression leading to hepatic steatosis "
            },
            {
                  "AOP_id": 61,
                  "AOP_name": "NFE2L2/FXR activation leading to hepatic steatosis "
            },
            {
                  "AOP_id": 72,
                  "AOP_name": "Epigenetic modification of PPARG leading to adipogenesis "
            },
            {
                  "AOP_id": 123,
                  "AOP_name": "Unknown MIE leading to reproductive dysfunction via increased HIF-1alpha transcription "
            },
            {
                  "AOP_id": 131,
                  "AOP_name": "Aryl hydrocarbon receptor activation leading to uroporphyria "
            },
            {
                  "AOP_id": 148,
                  "AOP_name": "EGFR Activation Leading to Decreased Lung Function "
            },
            {
                  "AOP_id": 200,
                  "AOP_name": "Estrogen receptor activation leading to breast cancer   "
            },
            {
                  "AOP_id": 318,
                  "AOP_name": "Glucocorticoid Receptor activation leading to hepatic steatosis "
            }
      ],
      "targets": [
            "C-C motif chemokine 2",
            "C-X-C motif chemokine 10",
            "Cytochrome P450 1A1",
            "Cytochrome P450 1A2",
            "Cytochrome P450 2B6",
            "Cytochrome P450 2C9",
            "Estrogen receptor alpha",
            "Fas-binding factor 1",
            "Interleukin-1 alpha",
            "Interstitial collagenase",
            "Nuclear receptor subfamily 1 group I member 2",
            "Steroidogenic factor 1",
            "Tumor necrosis factor",
            "UDP-glucuronosyltransferase 1-1",
            "cAMP-specific 3',5'-cyclic phosphodiesterase 4A"
      ]
}